首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Effect of diode laser trans-scleral cyclophotocoagulation in the management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments
【2h】

Effect of diode laser trans-scleral cyclophotocoagulation in the management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments

机译:二极管激光经巩膜循环光凝治疗玻璃体腔注硅油治疗复杂性视网膜脱离后青光眼的效果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIMS—To evaluate the effect of trans scleral cyclophotocoagulation (TSCPC) on intraocular pressure (IOP) in the eyes retaining intravitreal silicone oil with medically uncontrolled secondary glaucoma following intravitreal silicone oil injection.
METHODS—Medical records of 11 eyes of 11 patients who underwent TSCPC for medically uncontrolled glaucoma without pupillary block following intravitreal silicone oil injection for complicated retinal detachment were reviewed retrospectively. In all cases, intravitreal silicone oil was not removed for fear of retinal redetachment. Diode laser contact TSCPC was performed at a power of 1.5-2.5 W, for a duration of 2 seconds, and with 20-27 applications. IOP, number of glaucoma medications, and success rate were evaluated.
RESULTS—After a mean follow up period of 52.5 (SD 8.2) (range 42-68) weeks, the mean pretreatment level of IOP, 43.0 (14.4) (26-67) mmHg, had fallen to 14.5 (4.3) (7-20) mm Hg (p=0.003). The number of glaucoma medications was reduced from 2.6 (0.8) to 0.6 (1.0) (p= 0.005). Qualified success was achieved in nine eyes (81.8%) and complete success in six (54.5%). After TSCPC, patients' retinal status had not changed.
CONCLUSION—Patients with medically uncontrolled glaucoma secondary to intravitreal silicone oil injection can be treated with TSCPC in spite of the retained intravitreal silicone oil.

机译:目的-评估经巩膜循环光凝(TSCPC)对玻璃体内注射硅油后保留玻璃体内硅油伴有医学上无法控制的继发性青光眼的眼内压(IOP)的影响。
方法-11眼的医学记录回顾性分析了玻璃体腔内注注硅油后因复杂性视网膜脱离而接受TSCPC治疗的医学上不受控制的青光眼而无瞳孔阻滞的患者。在所有情况下,都不会去除玻璃体内硅油,以免视网膜脱离。二极管激光接触TSCPC的功率为1.5-2.5 W,持续时间为2秒,应用了20-27次。对IOP,青光眼用药数量和成功率进行了评估。
结果-在平均52.5(SD 8.2)(42-68)周的平均随访期后,IOP的平均预处理水平为43.0(14.4) (26-67)毫米汞柱,已降至14.5(4.3)(7-20)毫米汞柱(p = 0.003)。青光眼药物的数量从2.6(0.8)减少到0.6(1.0)(p = 0.005)。九眼(81.8%)获得合格的成功,六眼(54.5%)获得完全的成功。 TSCPC后,患者的视网膜状态没有改变。
结论—尽管玻璃体内硅油保留,但玻璃体腔内注射硅油的继发于医学上不受控制的青光眼的患者仍可以接受TSCPC治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号